Results 111 to 120 of about 19,943,678 (222)

Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement

Critical Care, 2019
There is a high degree of uncertainty regarding optimum care of patients with potential or known intake of oral anticoagulants and traumatic brain injury (TBI).
Marion Wiegele, Herbert Schöchl, Alexander Haushofer, Martin Ortler, Johannes Leitgeb, Oskar Kwasny, Ronny Beer, Cihan Ay, Eva Schaden   +8 more
doaj   +1 more source

Emerging risk factors influencing the occurrence of peri‐implantitis

Periodontology 2000, EarlyView.
Abstract Background The objective of the present review is to explore the evidence and biological plausibility of factors that may expose dental implants to a greater likelihood of developing peri‐implantitis. Material and Methods An electronic screening on the PubMed library the was carried out to identify potential emerging factors that influence the
Alberto Monje, Ronald E. Jung, Cristina Valles, Nadja Naenni   +3 more
wiley   +1 more source

Clinical Outcomes of Non Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Non Valvular Atrial Fibrillation Patients: A Cohort Study in a Rural Tertiary Care Hospital, Gujarat, India

Journal of Clinical and Diagnostic Research
Introduction: Atrial Fibrillation (AF) is the most common arrhythmia, with an increased risk of ischaemic stroke and subsequent morbidity and mortality. Oral anticoagulants such as Vitamin K Antagonists (VKAs) and non VKA Oral Anticoagulants (NOACs) are ...
Sohilkhan Riyazkhan Pathan, Bharat M Gajjar, Sunilkumar Karna, Kushal Pujara   +3 more
doaj   +1 more source

Prebiotic Bimuno® GOS reduces illness symptoms and supports gut barrier function and immunity after intermittent exercise in the heat

Experimental Physiology, EarlyView.
Abstract Exercise in hot climates increases the risk of gastrointestinal (GI) disruption and respiratory illness. We investigated the effects of a 42 day prebiotic intervention on markers of intestinal epithelial injury, GI discomfort and immunity following football specific exercise in the heat and daily upper respiratory illness.
Connor J. Parker, Samantha J. Abbott, Luke R. Butterfield, Kirsty A. Hunter, Michael A. Johnson, Graham R. Sharpe, Neil C. Williams   +6 more
wiley   +1 more source

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients [PDF]

Europace, 2014
This editorial refers to ‘Non-vitamin K antagonist oral anticoagulation agents (NOACs) in anticoagulant naive atrial fibrillation patients: Danish Nationwide Descriptive Data 2011–2013’ by J.B. Olesen et al ., on page 187–193. Atrial fibrillation (AF) is the commonest cardiac rhythm disorder and is associated with an increased risk of mortality and ...
openaire   +2 more sources

Feasibility and Safety Profile of Non‐anesthesiologist‐administered Propofol During Colorectal Endoscopic Submucosal Dissection: A Single‐center Study of 454 Procedures

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objectives Studies of non‐anesthesiologist‐administered propofol (NAAP) during colorectal endoscopic submucosal dissection (ESD) are scarce, particularly in the elderly. We evaluated its feasibility across a broad age range and identified factors associated with sedation‐related adverse events.
Yumi Kishi, Mayo Tanabe, Naoyuki Uragami, Daijiro Shiomi, Mai Fukuda, Miho Kurahashi, Toshiki Hanzawa, Michimasa Yamaguchi, Mikio Muraoka, Hatsuka Nakamura, Rei Miyake, Yukiko Okada, Yoichi Toyoda, Akiko Toshimori, Takayoshi Ito, Noboru Yokoyama, Haruhiro Inoue   +16 more
wiley   +1 more source

Beyond deficiency:Potential benefits of increased intakesof vitamin K for bone and vascular health [PDF]

, 2004
Vitamin K is wellknown for its role in the synthesisof a number of blood coagulationfactors.During recent years vitaminK-dependent proteins werediscovered to be of vital importancefor bone and vascular health.Recommendations for dietary vitaminK intake ...
Vermeer, C, Weber, P, Zittermann, A, Shearer, M, Szulc, P, Walter, P, Stocklin, E, Bolton-Smith, C, Rambeck, W, Hodges, S   +9 more
core  

Multivariate cox regression analysis for clinical outcomes in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs) compared to warfarin.

, 2019
Multivariate cox regression analysis for clinical outcomes in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs) compared to warfarin.
Robert Klempfner (326258), Maya Koren-Michowitz (267119), Nir Shlomo (686408), Ilan Goldenberg (326261), Yoav Michowitz (7832888)   +4 more
core   +1 more source

Non-vitamin K antagonist oral anticoagulants in the treatment of coronary and peripheral atherosclerosis

Kardiologia Polska, 2019
Oral anticoagulants (OACs) are widely used for prevention of systemic thromboembolism, including the reduction of the risk of stroke in patients with atrial fibrillation (AF) and prosthetic heart valves. There is also an increasing population of patients who require not only OACs, but also double antiplatelet therapy (DAPT).
Adam Witkowski, Marcin Barylski, Krzysztof J. Filipiak, Marek Gierlotka, Jacek Legutko, Maciej Lesiak, Janina Stępińska, Wojciech Wojakowski   +7 more
openaire   +3 more sources

Non-vitamin k antagonist oral anticoagulants in a European primary care physician survey

BJGP Open, 2018
Background: Familiarity and competency in the options for stroke prevention in atrial fibrillation (AF) and the role of non-vitamin K antagonist oral anticoagulants (NOACs) may vary among primary care physicians (PCPs) from different European countries ...
Claudio Cimminiello, Robert Hatala, Sami Pakarinen, Hernan Polo Friz, David Fitzmaurice, FD Richard Hobbs   +5 more
doaj   +1 more source